Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H12N2 |
| Molecular Weight | 232.2799 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cn1c2c(cc3ccccc13)nc4ccccc24
InChI
InChIKey=KURWKDDWCJELSV-UHFFFAOYSA-N
InChI=1S/C16H12N2/c1-18-15-9-5-2-6-11(15)10-14-16(18)12-7-3-4-8-13(12)17-14/h2-10H,1H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis. | 2019-05-01 |
|
| In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine. | 2017-12-28 |
|
| Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPKα1/2-LKB1. | 2017-05-04 |
|
| Cryptolepine and quindoline: understanding their photophysics. | 2017-04-19 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
480-26-2
Created by
admin on Mon Mar 31 18:59:50 GMT 2025 , Edited by admin on Mon Mar 31 18:59:50 GMT 2025
|
PRIMARY | |||
|
OF1UIT4RDH
Created by
admin on Mon Mar 31 18:59:50 GMT 2025 , Edited by admin on Mon Mar 31 18:59:50 GMT 2025
|
PRIMARY | |||
|
DTXSID6037645
Created by
admin on Mon Mar 31 18:59:50 GMT 2025 , Edited by admin on Mon Mar 31 18:59:50 GMT 2025
|
PRIMARY | |||
|
82143
Created by
admin on Mon Mar 31 18:59:50 GMT 2025 , Edited by admin on Mon Mar 31 18:59:50 GMT 2025
|
PRIMARY | |||
|
Cryptolepine
Created by
admin on Mon Mar 31 18:59:50 GMT 2025 , Edited by admin on Mon Mar 31 18:59:50 GMT 2025
|
PRIMARY |
METABOLITE (PARENT)
SUBSTANCE RECORD
